Countries are entering a critical phase in achieving the health Sustainable Development Goals (SDGs), with Universal Health Coverage (UHC)—ensuring access to essential health services without financial hardship—at the core of these efforts. With only six years remaining, progress in low- and lower-middle-income countries has been deeply inadequate, and setbacks from the COVID-19 pandemic have further derailed momentum.

Health financing is central to reversing this trajectory. While many factors contribute to these shortfalls, failures in health financing are particularly harmful, undermining all other aspects of the health system. Mobilizing funds adequately, pooling resources sufficiently, and spending them efficiently and equitably set the boundaries of what health systems can realistically achieve in providing essential services, ensuring financial protection, and strengthening public health functions.

To address these challenges, TEKANO Group established health financing as its first practice, tackling them through three core areas: the Academy, the Laboratory, and the Advisory. Each of these areas plays a distinct role: the Academy strengthens capacity, the Laboratory pushes the frontiers of health financing, and the Advisory provides strategic support for reforms. Together, these efforts enable countries to expand access to essential services, reduce financial hardship for vulnerable populations, and safeguard public health systems for the future.